Phase 2 Chronic Kidney Disease Trial, Recruiting NCT06903559 Sponsor: Mansoura University Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Phase 2 Chronic Kidney Disease Trial, Recruiting

NCT06903559
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults over 18 years of age.
  • People who are willing to sign a consent form agreeing to take part in the study.
  • People who have end-stage kidney disease and have been receiving regular hemodialysis (a machine-based kidney treatment) for more than 3 months.

Who may not be able to join:

  • People who are currently pregnant or breastfeeding.
  • People who have been diagnosed with cancer.
  • People who have a psychotic condition or who are currently taking sleeping medication.
  • People who decline to take part in the study.
  • People with a known history of blood disorders, or whose anemia (low red blood cell levels) has a cause other than kidney disease or dialysis.
  • People with severe heart or cardiovascular disease.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +201027794586

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Mansoura University
Registry
ClinicalTrials.gov
Start date
15 April 2025
Est. completion
15 October 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Change from Baseline in Left Ventricular Ejection Fraction (LVEF) at 6 Months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov